Overview of Mannitol Fresenius 15%
Quick Facts
| Property | Description |
|---|---|
| Active Ingredient | Mannitol (D-Mannitol) |
| Form | Sterile Solution for Infusion |
| Pharmacological Class | Osmotic Diuretic |
| General Purpose | Rapid reduction of elevated internal pressure |
| Origin | Derived Polyol (Sugar Alcohol) |
Defining Mannitol Fresenius 15%: Identity and Class
Mannitol Fresenius 15% is a sterile, single-ingredient preparation whose active compound is Mannitol, which is classified as an Osmotic Diuretic agent. This medication is utilized in acute clinical environments where rapid fluid management is critical. Chemically, Mannitol is a sugar alcohol or polyol (D-Mannitol), naturally occurring but purified for pharmaceutical use, placing its origin as derived rather than purely synthetic. The preparation is distinguished by its use in hospital settings for emergency pressure management, rather than standard chronic therapy.
The Pharmaceutical Form and Composition of Mannitol 15%
The specific preparation is a hyperosmolar crystalloid solution, meaning it has a solute concentration significantly greater than that of normal plasma. It consists of D-Mannitol at a specific 15% weight per volume (w/v) concentration, dissolved completely in an aqueous vehicle (Water for Injection). The 15% w/v concentration is delivered as a parenteral intravenous solution for infusion, which is essential for ensuring rapid systemic action. Mannitol injection is indicated as an osmotic diuretic for the promotion of diuresis, confirming its high-level function of increasing fluid elimination.
The General Therapeutic Purpose of Osmotic Action
The general goal of this osmotic agent is the rapid mobilization of excess fluid from body tissues, serving as a physical mechanism to control abnormally elevated pressure within confined anatomical spaces. When infused, Mannitol molecules create a powerful osmotic pressure gradient, which efficiently draws free water out of specific tissues and into the circulation. This critical action allows the drug to achieve its core benefit: the acute control of dangerously high pressure associated with tissue swelling, particularly in areas like the brain and eye.
Regulatory References

